Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Snell & Wilmer Attorney Caylye Nordling Joins Board of Directors of SafeNest
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
FAYETTEVILLE, Ark. & SEATTLE - nvtip -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network with the addition of CoMedical, a vascular access distribution company that services the Pacific Northwest. CoMedical, founded in 1980 and headquartered in Seattle Washington, is a medical device distributor specializing in the distribution and sale of vascular access products. CoMedical's sales team consisting of 6 members services Alaska, Idaho, Montana, Oregon and Washington on behalf of Lineus Medical.
"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest. We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients. SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access - the life line for many patients.", said Alison Donsky, Principal at CoMedical.
Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success. Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."
More on nvtip.com
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.
More on nvtip.com
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
MKG-0104
1D.I.P.P.E.R Study - Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest. We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients. SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access - the life line for many patients.", said Alison Donsky, Principal at CoMedical.
Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success. Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."
More on nvtip.com
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.
More on nvtip.com
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
MKG-0104
1D.I.P.P.E.R Study - Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
Source: Lineus Medical
Filed Under: Technology
0 Comments
Latest on nvtip.com
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Snell & Wilmer Attorney Caylye Nordling Joins Board of Directors of SafeNest
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
- FreeTo.Chat - The bold, Anonymous Confession Platform, ushers in a new era of tension relief
- Hyatt House Fresno Celebrates Grand Opening, Introducing the First Hyatt House in Fresno, California
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- House of Magic Las Vegas Announces Fundraiser for Green Valley High School Band Program
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- Automation Strategist Jeff Arnold to Deliver Keynote at The AI Collective Detroit
- London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
- myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test


